Ligand Pharmaceuticals shares owned by Simplex Trading
Quarter-by-quarter ownership of Ligand Pharmaceuticals shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Ligand Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Ligand Pharmaceuticals by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $100k | 500 | 199.65 |
| 2024-12-31 | $257k | 2.4k | 107.08 |
| 2024-09-30 | $650k | 6.5k | 100.00 |
| 2024-06-30 | $556k | 6.6k | 84.24 |
| 2024-03-31 | $1.2M | 17k | 73.05 |
| 2023-12-31 | $1.1M | 16k | 71.42 |
| 2023-09-30 | $940k | 16k | 59.87 |
| 2023-06-30 | $57k | 800 | 71.25 |
| 2023-03-31 | $51k | 900 | 56.67 |
| 2022-12-31 | $0 | 200 | 0.00 |
| 2022-09-30 | $86k | 1.0k | 86.00 |
| 2022-06-30 | $89k | 1.0k | 89.00 |
| 2022-03-31 | $33k | 300 | 110.00 |
| 2021-12-31 | $924k | 6.8k | 135.88 |
| 2021-09-30 | $924k | 6.8k | 135.88 |
| 2021-06-30 | $892k | 6.8k | 131.18 |
| 2021-03-31 | $670 | 44 | 15.23 |
| 2020-12-31 | $974 | 98 | 9.94 |
| 2020-09-30 | $408 | 43 | 9.51 |
| 2020-06-30 | $2.1k | 185 | 11.18 |
| 2020-03-31 | $967 | 133 | 7.27 |
| 2019-12-31 | $4.5k | 435 | 10.43 |
| 2019-09-30 | $2.9k | 287 | 9.95 |
| 2019-06-30 | $1.4k | 121 | 11.41 |
| 2019-03-31 | $3.1k | 250 | 12.57 |
| 2018-12-31 | $446 | 33 | 13.55 |
| 2018-09-30 | $850 | 31 | 27.42 |
| 2018-06-30 | $103 | 5 | 20.60 |
| 2018-03-31 | $703k | 4.2k | 166.23 |
| 2017-12-31 | $0 | 3 | 0.00 |
| 2017-09-30 | $0 | 1 | 0.00 |
| 2017-06-30 | $196k | 360 | 544.44 |
| 2017-03-31 | $0 | 1 | 0.00 |
| 2016-12-31 | $3.0k | 33 | 90.91 |
| 2016-09-30 | $9.0k | 53 | 169.81 |
| 2016-06-30 | $0 | 2 | 0.00 |
| 2015-09-30 | $0 | 2 | 0.00 |
| 2015-06-30 | $5.0k | 8 | 625.00 |
| 2015-03-31 | $4.0k | 11 | 363.64 |
Top funds holding Ligand Pharmaceuticals
View all funds holding Ligand Pharmaceuticals